Shin-Etsu

Abstract Poor aqueous solubility and thereby poor and/or variable bioavailability of drug candidates is frequently overcome by developing enabling formulations...

Abstract Topical dosage forms represent a critical segment of pharmaceutical products, offering localized drug delivery with minimal systemic exposure. This...

Abstract Amorphous solid dispersions (ASD) are an effective strategy to enhance the solubility of poorly water-soluble drugs. Hot melt extrusion...

The AAPS Annual Meeting 2025 is happening November 9-12, 2025, at the Henry B. Gonzalez Convention Center in San Antonio,...

Abstract Background: Solid dispersions (SDs) of etodolac (ETD), a poorly water-soluble drug model, were developed to enhance its solubility and dissolution...

Abstract PROTACs are an emerging class of beyond-rule-of-5 molecular drugs currently under clinical investigation for the treatment of malignant diseases...

Abstract The presence of N-nitrosamine impurities and nitrosamine drug substance-related impurities (NDSRIs) in medicines poses a significant challenge not only for...

PRESS RELEASE Huenstetten, 14 October 2025 – Shin-Etsu has selected Biogrund as its new distribution partner for pharmaceutical excipients in...

Abstract Lipid nanodispersions are a promising formulation strategy for improving the bioavailability of drugs that are poorly water-soluble but highly...

This year CPHI Europe opens its doors in Frankfurt at Messe Frankfurt. From 28th to 30th October you can have...